$Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial$

Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial

Humrich, Jens Y; von Spee-Mayer, Caroline; Siegert, Elise; Bertolo, Martina; Rose, Angelika; Abdirama, Dimas; Enghard, Philipp; Stuhlmüller, Bruno; Sawitzki, Birgit; Huscher, Dörte; Hiepe, Falk; Alexander, Tobias; Feist, Eugen; Radbruch, Andreas; Burmester, Gerd-Rüdiger; Riemekasten, Gabriela

期刊名称The Lancet Rheumatology
作者Humrich, Jens Y; von Spee-Mayer, Caroline; Siegert, Elise; Bertolo, Martina; Rose, Angelika; Abdirama, Dimas; Enghard, Philipp; Stuhlmüller, Bruno; Sawitzki, Birgit; Huscher, Dörte; Hiepe, Falk; Alexander, Tobias; Feist, Eugen; Radbruch, Andreas; Burmester, Gerd-Rüdiger; Riemekasten, Gabriela
卷第1卷
期第1期
印刷ISSN2665-9913
文件大小396.96KB
发表时间2019-09
DOI10.1016/S2665-9913(19)30018-9

发现好书期刊，享受阅读乐趣

Low-dose interleukin-2 therapy in refractory systemic lupus erythematosus: an investigator-initiated, single-centre phase 1 and 2a clinical trial